| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |